Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-008-7 | CAS number: 112-82-3
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 June to 01 July 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in compliance with agreed protocols, with no deviations from standard test guidelines and no methodological deficiencies, which do not affect the quality of the relevant results. The study report was conclusive, done to a valid guideline and the study was conducted under GLP conditions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- 1-bromohexadecane
- EC Number:
- 204-008-7
- EC Name:
- 1-bromohexadecane
- Cas Number:
- 112-82-3
- Molecular formula:
- C16H33Br
- IUPAC Name:
- 1-bromohexadecane
- Details on test material:
- - Substance type: White semi-solid block on arrival which melts into a clear colourless viscous liquid.
- Date received: 12th April 2002
- Storage condition of test material: Room temperature in a dark room
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd.
- Age at study initiation: 8 - 12 weeks old.
- Weight at study initiation: 182 - 206 g at day 0.
- Fasting period before study: Overnight fast before dosing then 3-4 hours after dosing.
- Housing: In groups of three in suspended solid floor polypropylene cages.
- Diet (e.g. ad libitum): Certified rat and mouse diet (Code 5LF2) supplied by PMI Nutrition International provided ad libitum.
- Water (e.g. ad libitum): Mains water ad libitum.
- Acclimation period: At least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature: 19 to 25°C
- Humidity: 30 - 70 %
- Air changes: 15 per hour
- Photoperiod (hrs dark / hrs light): 12 hours light 06:00 to 18:00, then 12 hours dark.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- Level: 2000 mg/kg body weight
Volume: 2.01 ml/kg body weight - No. of animals per sex per dose:
- Two groups consisiting of three individuals. Six rats were tested in total.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: 0.5, 1, 2 and 4 hours post dosing, then once daily for the 14 day duration.
- Frequency of weighing: Day 0 prior to dosing, then on days 7 and 14.
- Additional observations: Clinical and behavioural.
- Necropsy of survivors performed: yes
- Other examinations performed: All animals were subjected to gross pathological examination including: external examination, opening of the abdominal and thoracic cavities allowing examination of the major organs. Macroscopic abnormalities were recorded.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 500 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No reliability limits were given.
- Mortality:
- No deaths.
- Clinical signs:
- other: No systemic signs of toxicity.
- Gross pathology:
- No abnormalities recorded.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- Migrated information
- Conclusions:
- Under the conditions of the test, the LD50 of the test material was determined to be >2500 mg/kg body weight. The test material is therefore is unclassified according to Regulation 1272/2008.
- Executive summary:
In a GLP-compliant acute toxicity study conducted in accordance with standardised guideline OECD 423, the LD₅₀ of the test material was calculated by exposing six female Sprague Dawley rats to a dose of 2000 mg/kg of body weight via oral gavage. Under the conditions of the test no systemic signs of toxicity were reported over a period of 14 days and the LD₅₀ was determined to be >2500 mg/kg.
The test material is does not require classification according to Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
